Outlook Therapeutics Stock (NASDAQ: OTLK) stock price, news, charts, stock research, profile.
You can purchase shares of Outlook Therapeutics (NASDAQ:OTLK) through any online brokerage.
Other companies in Outlook Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Skye Bioscience (NASDAQ:SKYE), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM) and Inovio Pharmaceuticals (NASDAQ:INO).
Outlook Therapeutics has a consensus price target of $21.95.
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $5.69 last updated September 24, 2024 at 5:04 PM EDT.
There are no upcoming dividends for Outlook Therapeutics.
Outlook Therapeutics’s Q4 earnings are confirmed for Friday, December 20, 2024.
There is no upcoming split for Outlook Therapeutics.
Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.